Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Procalcitonin-Guided Algorithm on Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis: a Randomized Controlled Study (Pro-Can)

NCT04203524 is registered in ClinicalTrials.gov with King Hussein Cancer Center as lead sponsor.

NCT NCT04203524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04203524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Procalcitonin-Guided Algorithm on Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis: a Randomized Controlled Study (Pro-Can)
Lead sponsor
King Hussein Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
August 21, 2019
Completion date
March 1, 2023
Enrollment
157 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, neoplasm, sepsis, septic shock